Laboratorios Farmaceuticos ROVI SA

LSE:0ILL

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0ILL's stock price target?

Price Target

81.46 EUR

According to Wall Street analysts, the average 1-year price target for 0ILL is 81.46 EUR with a low forecast of 64.79 EUR and a high forecast of 104.91 EUR.

What is the Revenue forecast for Laboratorios Farmaceuticos ROVI SA?

Projected CAGR

9%

Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 5 years is 9%.

What is the Gross Profit forecast for Laboratorios Farmaceuticos ROVI SA?

Projected CAGR

12%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 5 years is 12%.

What is the Operating Income forecast for Laboratorios Farmaceuticos ROVI SA?

Projected CAGR

16%

Over the last 14 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 5 years is 16%.

What is the Pre-Tax Income forecast for Laboratorios Farmaceuticos ROVI SA?

Projected CAGR

20%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 20%.

What is the Net Income forecast for Laboratorios Farmaceuticos ROVI SA?

Projected CAGR

15%

Over the last 14 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 5 years is 15%.